Loxo Oncology Analysis
Loxo Oncology is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Loxo Oncology delisted stock analysis is to determine its intrinsic value, which is an estimate of what Loxo Oncology is worth, separate from its market price. There are two main types of Loxo Oncology's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Loxo Oncology's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Loxo Oncology's stock to identify patterns and trends that may indicate its future price movements.
The Loxo Oncology stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Loxo Oncology is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Loxo Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Loxo Oncology's ongoing operational relationships across important fundamental and technical indicators.
Loxo |
Loxo Stock Analysis Notes
About 93.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.09. Loxo Oncology had not issued any dividends in recent years. Loxo Oncology, Inc., a biopharmaceutical company, develops and sells medicines for patients with genetically defined cancers in the United States. Loxo Oncology, Inc. was founded in 2013 and is headquartered in Stamford, Connecticut. Loxo Oncology operates under Biotechnology classification in USA and is traded on NASDAQ General Markets. It employs 59 people. To find out more about Loxo Oncology contact Joshua Bilenker at 203 653-3880 or learn more at www.loxooncology.com.Loxo Oncology Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Loxo Oncology's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Loxo Oncology or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Loxo Oncology is not yet fully synchronised with the market data | |
| Loxo Oncology has some characteristics of a very speculative penny stock | |
| Loxo Oncology has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 144.8 M. Net Loss for the year was (62.98 M) with loss before overhead, payroll, taxes, and interest of (118.74 M). | |
| Over 93.0% of the company shares are owned by institutional investors |
Loxo Oncology Thematic Classifications
In addition to having Loxo Oncology stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | Cancer FightersPublic companies from health care and pharmaceutical sectors that are focused on fighting cancer |
Loxo Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.22 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Loxo Oncology's market, we take the total number of its shares issued and multiply it by Loxo Oncology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Loxo Profitablity
Loxo Oncology's profitability indicators refer to fundamental financial ratios that showcase Loxo Oncology's ability to generate income relative to its revenue or operating costs. If, let's say, Loxo Oncology is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Loxo Oncology's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Loxo Oncology's profitability requires more research than a typical breakdown of Loxo Oncology's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (43.49) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (50.33) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $50.33.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Loxo Oncology to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Loxo Stock
If you are still planning to invest in Loxo Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Loxo Oncology's history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |